electroCore (ECOR) Expected earnings per share growth for next year
Business resilience during its defensive development phase has isolated electroCore, Inc. (ECOR) from macro risks, triggering an upward revision in analyst expectations for EPS growth in the next fiscal year. The 81.10 mark captures this metric. This positive sentiment is bolstered by the company's leadership in bioelectronics for migraine therapy and efficient device manufacturing within the US, the adoption of which is supported by expanding insurance coverage.
Analytical breakdowns for electroCore (ECOR)
- share price and consensus valuation forecast:
- market capitalization details:
- book capitalization information:
- company total debt and liquidity indicators:
Total Debt to Capital electroCore, Inc.|ECOR - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital electroCore Inc|ECOR - Company Total Debt Obligations|Debts to Book Capitalization electroCore|ECOR - Company Long-Term Liabilities|Company Short-Term Debts electroCore|Quick Liquidity electrocore.com
- net income and valuation ratios data:
ECOR - Company Net Income|Future Profit electroCore, Inc.|ECOR - Company Value to Net Income|Forward P/E Multiple electroCore Inc|ECOR - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore|ECOR - Operating profit before depreciation charges|Net earnings per share for the last 12 months electroCore|ECOR - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth electrocore.com|ECOR - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year electroCore, Inc.
Initial company analysis:electroCore, Inc., ECOR
The resilience of electroCore, Inc. (ECOR) to market volatility is driven by its ability to monetize neuro-hardware developments, including the expanded application of gammaCore systems for PTSD therapy. This factor directly impacts consolidated expert forecasts for future revenues. By analyzing the trend of expected earnings per share, investors assess the quality of corporate disclosures, where a prolonged upward trajectory may signal an asset overvaluation.
Analysis of competing companies
DXCM (Dexcom Corp) - Earnings growth forecast for next year|Expected earnings per share growth for next year Penumbra Medical (PEN)|Expected earnings per share growth for next year NOVT (Novanta Inc.)|HAE (haemonetics.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Inspire Medical Systems, Inc. INSP|PRCT - Expected earnings per share growth for next year|CONMED Corp. - Earnings growth forecast for next year|Expected net earnings per share growth next year Pulse Medical|INMD: Earnings growth forecast for next year|Projected earnings per share growth rate for next year PMI|SRDX (Surmodics) - Earnings growth forecast for next year|Senseonics Holdings Inc (SENS) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year NPCE|Expected earnings per share growth for next year tactilemedical.com TCMD|Earnings growth forecast for next year SNWV (Sanuwave Health Inc)|Earnings growth forecast for next year outsetmedical.com OM|ELMD - Net earnings per share growth forecast for next year|LNSR: Net earnings per share growth forecast for next year|RCEL (AVITA Medical, Inc) - Expected earnings per share growth for next year|Profound Medical - Expected earnings per share trend next year|BDMD (Baird Medical Investment Holdings) - Earnings growth forecast for next year|Expected net earnings per share growth next year EDAP Medical EDAP|Net earnings per share growth forecast for next year Apyx Medical (APYX)|icecure-medical.com (ICCM) - Net earnings per one share growth forecast for next year|Pulmonx - Expected earnings per share growth for next year|Earnings growth forecast for next year TELA Bio Inc. TELA|CytoSorbents Corp. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year sensushealthcare.com SRTS|Zynex (ZYXI) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year RBOT (Vicarious Surgical)|Net earnings per share growth forecast for next year Inspira Technologies Oxy B.H.N. Ltd.|Expected earnings per share growth for next year SeaStar Medical Holding Corp. (ICU)|Earnings growth forecast for next year IRIX|INBS - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Beyond Air XAIR|PFSA: Projected earnings per share growth rate for next year|SSKN: Expected earnings per share growth for next year|glucotrack.com - Projected earnings per share increase next year|NAOV: Earnings growth forecast for next year|Expected net earnings per share growth next year venusconcept.com (VERO)|Net earnings per share growth forecast for next year Nuwellis|Net earnings per share growth forecast for next year AEMD|Earnings growth forecast for next year ASXC|AVGR - Expected net earnings per share growth next year|Earnings growth forecast for next year BSGM (BioSig Technologies)|CUTR - Expected earnings per share growth for next year|KNW: Expected earnings per share growth for next year|Inari Medical Inc - Projected earnings per share increase next year|Nevro Corporation (NVRO) - Net earnings per share growth forecast for next year|ReShape Lifesciences Inc. - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Silk Road Medical, Inc
